SCHEMBL19489059

SCHEMBL19489059

CC(N)C1CCCC(C(=O)NC2CCCCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.50
ROCK2 O75116 3/20 0.46
ROCK1 Q13464 3/20 0.46
PKN2 Q16513 3/20 0.46
TSHR P16473 3/20 0.46
CYP3A4 P08684 3/20 0.46
CYP2D6 P10635 2/20 0.46
RPS6KA5 O75582 2/20 0.46
LRRK2 Q5S007 2/20 0.46
HTT P42858 2/20 0.46
TP53 P04637 2/20 0.46
HRH3 Q9Y5N1 1/20 0.46
CHUK O15111 1/20 0.46
PRKD3 O94806 1/20 0.46
CDK1 P06493 1/20 0.46
CDK2 P24941 1/20 0.46
LTK P29376 1/20 0.46
CDK8 P49336 1/20 0.46
PRKX P51817 1/20 0.46
CDK5 Q00535 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18809970 1.00 EPHX2 (0.50) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18809737 1.00 EPHX2 (0.50) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL19489363 1.00 EPHX2 (0.50) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18431022 1.00 EPHX2 (0.50) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18947254 0.98 EPHX2 (0.51) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18431034 0.98 EPHX2 (0.51) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18947232 0.98 EPHX2 (0.51) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL19489277 0.98 EPHX2 (0.48) EPHX2ROCK2ROCK1PKN2TSHR
SCHEMBL18431023 0.97 EPHX2 (0.52) EPHX2TSHRCYP2D6HTTHRH3
SCHEMBL18431059 0.97 EPHX2 (0.52) EPHX2TSHRCYP2D6HTTHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3231798-A1 THIAZOLE INTERMEDIATES USEFUL IN THE PREPARATION OF RAF KINASE INHIBITORS Sunesis Pharmaceuticals, Inc. (US) 2017-10-18 EP disclosed